Chien-Feng Chen
Overview
Explore the profile of Chien-Feng Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nissen S, Lincoff A, Brennan D, Ray K, Mason D, Kastelein J, et al.
N Engl J Med
. 2023 Mar;
388(15):1353-1364.
PMID: 36876740
Background: Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on cardiovascular outcomes...
2.
Chiang T, Chen C, Li Y, Chen Y
J Dent Sci
. 2019 Mar;
13(3):281-282.
PMID: 30895133
No abstract available.
3.
Sellers E, Schoedel K, Bartlett C, Romach M, Russo E, Stott C, et al.
Clin Pharmacol Drug Dev
. 2016 Apr;
2(3):285-94.
PMID: 27121791
Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray has proved efficacious in the treatment of spasticity in multiple sclerosis and chronic pain. A thorough QT/QTc study was performed to investigate the effects of...
4.
Blair J, Khan S, Konstam M, Swedberg K, Zannad F, Burnett Jr J, et al.
Eur Heart J
. 2009 May;
30(13):1666-73.
PMID: 19411662
Aims: Increases in body weight (BW) are important determinants for hospitalization in ambulatory patients with heart failure (HF), but have not yet been explored in patients hospitalized for worsening HF....
5.
Newland A, Caulier M, Kappers-Klunne M, Schipperus M, Lefrere F, Zwaginga J, et al.
Br J Haematol
. 2006 Oct;
135(4):547-53.
PMID: 17061981
Abstract The objective of this open label, phase 1-2, multicentre trial was to evaluate the safety of AMG 531, a novel thrombopoiesis-stimulating peptibody, and its effect on platelet counts in...
6.
Bussel J, Kuter D, George J, McMillan R, Aledort L, Conklin G, et al.
N Engl J Med
. 2006 Oct;
355(16):1672-81.
PMID: 17050891
Background: Most current treatments for chronic immune thrombocytopenic purpura (ITP) act by decreasing platelet destruction. In a phase 1-2 study, we administered a thrombopoiesis-stimulating protein, AMG 531, to patients with...